vs
NETSTREIT Corp.（NTST）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是NETSTREIT Corp.的1.3倍（$75.5M vs $57.1M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 24.3%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 20.1%）
NETSTREIT Corp.是一家总部位于美国的房地产投资信托（REIT），专注于收购和运营多元化的单租户净租赁商业物业组合，资产涵盖零售、工业、办公类别，主要服务于美国市场的投资级企业租户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NTST vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$57.1M
营收增速更快
PBYI
高出3.4%
24.3%
两年增速更快
PBYI
近两年复合增速
20.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.1M | $75.5M |
| 净利润 | $5.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 34.1% | 22.7% |
| 净利率 | 10.0% | — |
| 营收同比 | 24.3% | 27.7% |
| 净利润同比 | 235.9% | — |
| 每股收益（稀释后） | $0.32 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NTSTPBYI
| Q1 26 | $57.1M | — | ||
| Q4 25 | $52.5M | $75.5M | ||
| Q3 25 | $48.3M | $54.5M | ||
| Q2 25 | $48.3M | $52.4M | ||
| Q1 25 | $45.9M | $46.0M | ||
| Q4 24 | $44.1M | $59.1M | ||
| Q3 24 | $41.4M | $80.5M | ||
| Q2 24 | $39.6M | $47.1M |
净利润NTSTPBYI
| Q1 26 | $5.7M | — | ||
| Q4 25 | $1.3M | — | ||
| Q3 25 | $618.0K | $8.8M | ||
| Q2 25 | $3.3M | $5.9M | ||
| Q1 25 | $1.7M | $3.0M | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $-5.3M | $20.3M | ||
| Q2 24 | $-2.3M | $-4.5M |
毛利率NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率NTSTPBYI
| Q1 26 | 34.1% | — | ||
| Q4 25 | 2.6% | 22.7% | ||
| Q3 25 | 1.3% | 17.6% | ||
| Q2 25 | 6.8% | 12.7% | ||
| Q1 25 | 3.7% | 8.7% | ||
| Q4 24 | -12.3% | 22.6% | ||
| Q3 24 | -12.8% | 27.4% | ||
| Q2 24 | -5.8% | -4.6% |
净利率NTSTPBYI
| Q1 26 | 10.0% | — | ||
| Q4 25 | 2.5% | — | ||
| Q3 25 | 1.3% | 16.2% | ||
| Q2 25 | 6.8% | 11.2% | ||
| Q1 25 | 3.7% | 6.5% | ||
| Q4 24 | -12.3% | — | ||
| Q3 24 | -12.8% | 25.2% | ||
| Q2 24 | -5.8% | -9.6% |
每股收益（稀释后）NTSTPBYI
| Q1 26 | $0.32 | — | ||
| Q4 25 | $0.01 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $0.04 | $0.12 | ||
| Q1 25 | $0.02 | $0.06 | ||
| Q4 24 | $-0.07 | $0.40 | ||
| Q3 24 | $-0.07 | $0.41 | ||
| Q2 24 | $-0.03 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.5B | $130.3M |
| 总资产 | $2.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $22.7M | ||
| Q3 25 | $1.1B | $34.0M | ||
| Q2 25 | $926.6M | $45.3M | ||
| Q1 25 | $913.3M | $56.7M | ||
| Q4 24 | $868.3M | $68.0M | ||
| Q3 24 | $778.7M | $79.3M | ||
| Q2 24 | $726.2M | $90.7M |
股东权益NTSTPBYI
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.4B | $130.3M | ||
| Q3 25 | $1.3B | $115.3M | ||
| Q2 25 | $1.3B | $104.7M | ||
| Q1 25 | $1.3B | $97.1M | ||
| Q4 24 | $1.3B | $92.1M | ||
| Q3 24 | $1.3B | $71.1M | ||
| Q2 24 | $1.3B | $48.5M |
总资产NTSTPBYI
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.6B | $216.3M | ||
| Q3 25 | $2.5B | $202.9M | ||
| Q2 25 | $2.3B | $194.9M | ||
| Q1 25 | $2.3B | $196.2M | ||
| Q4 24 | $2.3B | $213.3M | ||
| Q3 24 | $2.2B | $220.7M | ||
| Q2 24 | $2.1B | $205.0M |
负债/权益比NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | 0.17× | ||
| Q3 25 | 0.84× | 0.30× | ||
| Q2 25 | 0.70× | 0.43× | ||
| Q1 25 | 0.70× | 0.58× | ||
| Q4 24 | 0.65× | 0.74× | ||
| Q3 24 | 0.58× | 1.12× | ||
| Q2 24 | 0.55× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | $109.5M | $14.4M | ||
| Q3 25 | $28.0M | $9.7M | ||
| Q2 25 | $30.6M | $14.1M | ||
| Q1 25 | $22.1M | $3.6M | ||
| Q4 24 | $90.2M | $15.6M | ||
| Q3 24 | $25.1M | $11.0M | ||
| Q2 24 | $25.4M | $1.0M |
自由现金流NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率NTSTPBYI
| Q1 26 | — | — | ||
| Q4 25 | 82.46× | — | ||
| Q3 25 | 45.27× | 1.10× | ||
| Q2 25 | 9.36× | 2.41× | ||
| Q1 25 | 13.06× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |
PBYI
暂无分部数据
